follow the cohorts , it will be nice if the company can interview cohort 1 first , then have like a 60min show covering them on channel 9, it will show us the results , really hope it saves lifes and be good investment for us shareholders , very early days , we know its outstanding results for 6 month's with C1(cohort one ) two studies running now ,
terms of revenue ? has it captured any of the market ATM? atm this market is $2-4? b globally? so lets say avr captures 10% of the market, from now on , thats about $300m usa very nice , whats the profit out of that ? $50m ? now whats the revenue as this market grows 25% annually, really big opportunity here ? huge takeover target ? question will AVR do it alone or just get bought out ? what's it worth with the current results? size of the revenue? $2b-$4b all am i completely wrong and this is not as good we think it is ?
big presentation coming in november
- Forums
- ASX - By Stock
- AVR
- Anteris Channel 9 Interview 2022
AVR
anteris technologies global corp.
Add to My Watchlist
6.09%
!
$6.27

Anteris Channel 9 Interview 2022, page-69
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M |
Open | High | Low | Value | Volume |
$5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 480 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1000 | 6.000 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
6.270 | 480 | 2 |
6.300 | 463 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online